Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Apotek HjärtatApotek Hjärtat
VS
Ipca Laboratories LimitedIpca Laboratories Limited
Apotek Hjärtat

Apotek Hjärtat

Kolonnvägen 20, Solna, Stockholm , 169 70, SE

Last Update: 04/03/2026

View Profile
Between 750 and 799
http://www.apotekhjartat.se
761/1000Fair

På Hjärtat har vi ett fantastiskt uppdrag: vi hjälper människor att må bättre.  Vi finns för alla i Sverige – för de sjuka och för de friska, genom livets alla faser. Med apotek i hela landet och en e-handel som aldrig stänger, finns vi alltid nära. Vi är över 4000 koll...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:2,598
Subsidiaries:2
12-month incidents
0
Known data breaches
0
Attack type number
0
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.ipca.com/
768/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Apotek Hjärtat

Apotek Hjärtat

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Apotek Hjärtat in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incident History - Apotek Hjärtat (X = Date, Y = Severity)

Apotek Hjärtat cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Apotek Hjärtat

Apotek Hjärtat

Incidents
No explicit notable incidents reported.
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has the best AI Cybersecurity Score ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced more cyber incidents in the past ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced more cyber incidents this year ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced at least one ransomware attack ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced at least one data breach ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced at least one targeted cyberattack ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has experienced at least one vulnerability ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one holds the most compliance certifications ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one holds the fewest compliance certifications ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has the most subsidiaries ?
Between Apotek Hjärtat company and Ipca Laboratories Limited company, which one has the largest number of employees ?
Between Apotek Hjärtat and Ipca Laboratories Limited, which company holds both SOC 2 Type 1 certifications ?
Between Apotek Hjärtat and Ipca Laboratories Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Apotek Hjärtat or Ipca Laboratories Limited ?
Which company is PCI DSS compliant - Apotek Hjärtat or Ipca Laboratories Limited ?
Between Apotek Hjärtat and Ipca Laboratories Limited, which company complies with HIPAA regulations for healthcare data ?
Between Apotek Hjärtat and Ipca Laboratories Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9